*Results obtained from previous Dexcom device(s) in patients with diabetes †Cardiovascular risk refers to 10-year ASCVD risk.
Visit https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/ to access the American College of Cardiology ASCVD Risk Estimator Plus. †Tips from the AI coach are not medical advice.
1Kierans, SJ, Taylor CT, et al. J Biol Chem. 2024; 300(11):107906. 2 Hantzidiamantis PJ, Awosika AO, Lappin SL, et al. StatPearls. 2024. 3 Mergenthaler P, Lindauer U, Dienel GA, Meisel A, et al. Trends Neurosci. 2013; 36(10):587–597. 4 Reed J, et al. Diabetes Obes Metab.2024;26(7):2881-9. 5 Dexcom, Data on File, 2025. 6 MacDonald AJ, Yang YHC, Cruz AM, Beall C, Ellacott KLJ, et al. Front Endocrinol (Lausanne). 7 Holzer R, et al. Sensors. 2022;22(5):2030. 8 Röder PV, et al. Exp Mol Med. 2016;48:e219. 9 Freeman AM et al. Insulin Resistance. StatPearls. 2026. 10 Stelo User Guide. 11 Crawford M, et al. Diabetes. 2025;74(Supp 1):2020–LB. 12 Dexcom survey of Stelo users (n=418). Data on File, 2024
MAT-4889